Labshake search
Citations for Tocris :
301 - 350 of 1763 citations for 6 Amino 4 hydroxy 3 7 sulfo 4 4 sulfophenyl azo 1 naphthyl azo naphthalene 2 7 disulfonic acid sodium salt since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2021Quote: ... Quinpirole 0.25-4 mg/L diluted in H2O (Tocris #1061) was administered by immersion for 1 hour.
-
bioRxiv - Neuroscience 2022Quote: ... 100 μM of CGP 54626 (Tocris, CAS: 149184-21-4) and 250 μM of picrotoxin (Sigma-Aldrich ...
-
bioRxiv - Neuroscience 2023Quote: ... 4-AP (100 µM, Tocris, 0940, CAS: 504-24-5), CNQX (20 µM ...
-
bioRxiv - Neuroscience 2024Quote: ... NE-100 (CAS#:149409-57-4) was purchased from Tocris Bioscience (Ellisville MO) ...
-
bioRxiv - Microbiology 2023Quote: ... The green fluorescent D-amino acid BADA32 (Tocris Bioscience) was added to a final concentration of 0.5 mM and tubes were incubated at 30°C with shaking for 90 min ...
-
bioRxiv - Neuroscience 2019Quote: ... (9S,10R,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3’,2’,1’-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid methyl ester (K252a, 200 nM) (Tocris), 7,8-Dihydroxy-2-phenyl-4H-1-benzopyran-4-one (DHF ...
-
bioRxiv - Neuroscience 2022Quote: ... 12-well plates at 3-4 × 105 cells/well in mTeSR1 with 10 µM rho-kinase inhibitor (Y-27632; Tocris, 1254). Medium without the inhibitor was replaced daily until the cells reach 80-100% confluency ...
-
bioRxiv - Biochemistry 2022Quote: ... Positive clones were analyzed by Sanger sequencing with primers #3 and #4 (Integrated DNA Technologies, Supplementary Table S5) and degradation upon dTAG-13 (Tocris, 6605) treatment was confirmed by Western Blot by a-Chaf1a antibody (65) ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with FGF-2 (20 ng ml−1), Activin-A (50 ng ml−1), BMP-4 (10 ng ml−1, R&D) and LY294002 (10 mM Tocris). Media was changed again after 42 hours to CDM-BSA supplemented with FGF-2 (8 ng ml−1) ...
-
bioRxiv - Developmental Biology 2020Quote: ... and 10 μM ALK4/5/7 kinase inhibitor SB431542 (Tocris) at 37 °C in 5% CO2 ...
-
bioRxiv - Neuroscience 2019Quote: ... 7-dinitroquinoxaline-2,3-dione (DNQX, Tocris, 50 μM final concentration) or cyano-7-nitroquinoxaline-2 ...
-
bioRxiv - Cancer Biology 2022Quote: ... 25 μM ML-7 (Tocris, myosin light-chain kinase inhibitor), 500 μM carbenoxolone (Sigma ...
-
bioRxiv - Neuroscience 2022Quote: ... CaM binding buffer was supplemented with 100μM W-7 (Tocris).
-
bioRxiv - Neuroscience 2023Quote: ... Ketanserin tartrate (Tocris Biosciences, CAS 83846-83-7; 1.5mg/kg), MDL100907 (volinanserin ...
-
bioRxiv - Neuroscience 2021Quote: ... 4- aminopyridine (Tocris Bioscience, 50 µM, 5 min-2hrs or 20hrs), AP5 (Tocris Bioscience ...
-
bioRxiv - Neuroscience 2020Quote: ... and the aquaporin-4 channel inhibitor TGN-020 (Tocris; 100 μM) were co-applied (n=16) ...
-
bioRxiv - Physiology 2021Quote: ... and/or 4) 100 nM ONO-8130 (Tocris Bioscience, Bristol, UK). In the latter two conditions ...
-
bioRxiv - Neuroscience 2023Quote: ... 50 µM CGP54626 Hydrochloride (1088/10, TOCRIS, CAS 149184-21-4), 200 µM (low dose ...
-
bioRxiv - Cell Biology 2022Quote: To observe chromosome alignment in fixed-cell experiments – with the advantage of taking high resolution images and easily selecting many cells for further analysis - cells were released from thymidine block for 7 hours before being treated for 2 hours with RO-3306 (10μM, Tocris) – to synchronise cells at the G2/M boundary - or with a 3-hour treatment with STLC (10μM ...
-
bioRxiv - Neuroscience 2020Quote: The FPR2 agonist Compound-43 (N-(4-Chlorophenyl)-N-[2,3-dihydro-1-methyl-5-(1-methylethyl)-3-oxo-2-phenyl-1H-pyrazol-4-yl]-urea) and antagonist WRW4 (Trp-Arg-Trp-Trp-Trp-NH2) were purchased from Tocris Ltd ...
-
bioRxiv - Neuroscience 2023Quote: ... and (3-chloro-4-fluoro-N-[(4-([2-(phenylcarbonyl)hydrazino]carbonyl) phenyl)methyl]benzene-sulfonamide) (TCN-201) (Hansen et al., 2012)were obtained from Tocris Bioscience ...
-
bioRxiv - Neuroscience 2019Quote: ... To block NMDA receptors we used D- (-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris, 10 μM final concentration). To block glycinergic inhibition ...
-
bioRxiv - Neuroscience 2020Quote: ... 20 μM 6,7-dinitroquinoxaline-2,3-dione (DNQX) and 20 μM D-(-)-2-amino-5-phosphopentanoic acid (D-AP5) (Tocris Bioscience) to block glycine- ...
-
bioRxiv - Biochemistry 2021Quote: ... neurons at DIV 7 were made quiescent by 1 μM tetrodotoxin (TTX; 1078, Tocris, Minneapolis, MN) overnight ...
-
bioRxiv - Cell Biology 2022Quote: ... animals received 7 intraperitoneal injection of 1mg/kg quinpirole (Quin; Tocris) dissolved in 0.9% saline every 72 hours ...
-
bioRxiv - Developmental Biology 2019Quote: ... From day 2 to day 4 the medium was additionally supplemented with BMP and TGFβ inhibitors (Noggin, Peprotech and SB431542, Tocris Bioscience). Treatment with MEK inhibitor (PD184352 ...
-
bioRxiv - Neuroscience 2020Quote: ... Cultures treated for 4 h with NMDA (50 μg/ml; Tocris #0114) and cultures incubated for 2 h with PI after fixation (referred to as ‘post-fixation’ ...
-
bioRxiv - Neuroscience 2019Quote: ... and 5 µg/ml Bovine Serum Albumin) containing 4 µM CHIR99021 (Tocris), 3 µM SB431542 (Sigma) ...
-
bioRxiv - Cell Biology 2020Quote: ... 5 mg/kg BW for 2,3-bis(4-Hydroxyphenyl)-propionitrile (DPN, Tocris), or vehicle ...
-
bioRxiv - Neuroscience 2022Quote: ... Cultures treated for 4 h with NMDA (50 μg/ml; #0114 Tocris) served as positive controls in these experiments ...
-
bioRxiv - Genomics 2023Quote: ... 2,3-Bis(4-hydroxyphenyl)propionitrile (DPN, 5 mg/kg body weight, Tocris) and 4-(2-(3,5-dimethylisoxazol-4-yl)-1H-indol-3-yl)phenol (DIP ...
-
bioRxiv - Neuroscience 2023Quote: ... we tested effects of an inhibitor (the spider toxin GsMTX 4; Tocris #4912 stock 50 μM in DMSO and the Piezo1 channel activator Yoda1 (Tocris 6586 10 and 20 uM ...
-
bioRxiv - Bioengineering 2024Quote: ... CDM was supplemented with 4 μM CHIR99021 (Tocris Bioscience, cat. no. 4423), and from day 2 to day 4 ...
-
bioRxiv - Neuroscience 2020Quote: ... During BQA experiments the ACSF solution contained the following substances: 10 μM D-(−)-2-Amino-5-phosphonopentanoic acid (D-AP5) (Tocris), 10 μM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX ...
-
bioRxiv - Neuroscience 2021Quote: ... NMDA receptor (R) dependency was tested by application of an NMDAR antagonist (APV 50 µM, DL-2-Amino-5-phosphonopentanoic acid, Tocris, Germany) in the bath solution ...
-
bioRxiv - Neuroscience 2023Quote: ... The following compounds were added to raCSF as indicated in the Results section: D-(-)-2-Amino-5-phosphonopentanoic acid (D-APV, 100 μM dissolved in H2O; Tocris Bioscience), (5S,10R)-(+)-5-Methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine maleate (MK-801 ...
-
bioRxiv - Neuroscience 2022Quote: ... Day 7: proliferation was inhibited with an overnight 10 μM floxuridine (Tocris) -treatment ...
-
bioRxiv - Neuroscience 2023Quote: ... 7-(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester (CPCCOEt, Tocris®); Tetrodotoxin (TTX ...
-
bioRxiv - Bioengineering 2023Quote: ... and TGF-Beta inhibitor (SB431542, Tocris # 1614, 5 μM, days 0-7). Media was changed on days 3 and 6 and then every 2-3 days until day 7 ...
-
bioRxiv - Neuroscience 2021Quote: ... washed with 4-5 ml ice cold PBS supplemented with 0.5 % BSA (Tocris), and collected by centrifugation for 10 min (300 g) ...
-
bioRxiv - Immunology 2021Quote: ... The non-selective MIF family cytokine inhibitor 4-IPP was obtained from Tocris Bioscience.
-
bioRxiv - Cancer Biology 2023Quote: ... The N2/B27 medium was supplemented with 4 µM Dorsomorphin (Tocris, Cat # 3039) and 10 µM SB431542 (Tocris ...
-
bioRxiv - Bioengineering 2024Quote: ... supplemented with 50 ng/mL bone morphogenetic protein 4 (BMP4; Tocris; 314-BP) and 100 ng/mL activin A (Tocris ...
-
bioRxiv - Bioengineering 2024Quote: ... supplemented with 50 ng/mL bone morphogenetic protein 4 (BMP4; Tocris; 314-BP) and 100 ng/mL activin A (Tocris ...
-
bioRxiv - Neuroscience 2019Quote: ... a final group of animals (n=4) received a DBB infusion of K-234 (1 nmol/0.5 µl/per side; Tocris Bioscience ...
-
bioRxiv - Neuroscience 2020Quote: ... containing 10 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 50 μM D,L-2-amino-5-phosphonovaleric acid (AP5) to block glutamatergic signaling (both from Tocris, Bristol, UK). Experiments involving tetrodotoxin (TTX ...
-
bioRxiv - Cell Biology 2022Quote: At day 0 cells were treated with 5 nM 4-Hydroxytamoxifen (+HOT) (Tocris, 3412) or with vehicle (-HOT ...
-
bioRxiv - Immunology 2019Quote: ... inhibitor of β1 integrin very late antigen (VLA-4) (Bio1211, 10 μM, Tocris bioscicence), inhibitor of macrophage-1 (MAC-1 ...
-
bioRxiv - Immunology 2021Quote: ... Sections were blocked with 4% bovine serum albumin (Tocris bioscience, catalogue# 9048-46-8), 5% normal goat serum (Invitrogen ...
-
bioRxiv - Bioengineering 2022Quote: ... the EBs were transferred to DMEM high glucose media with XAV (4□uM, TOCRIS) and then transferred to maturation media [DMEM containing low glucose (2□g/L ...